Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C88638
http://purl.obolibrary.org/obo/NCIT_C88638
|
|---|---|
| Preferred Name | Clivatuzumab |
| Definitions |
A humanized monoclonal antibody directed against the pancreatic cancer antigen MUC1, with potential antineoplastic activity. Clivatuzumab binds to tumor cells expressing the MUC1 antigen and prevents MUC1-mediated signaling. MUC1, a mucin antigen, is overexpressed in pancreatic cancer but not in normal, healthy pancreatic cells.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A humanized monoclonal antibody directed against the pancreatic cancer antigen MUC1, with potential antineoplastic activity. Clivatuzumab binds to tumor cells expressing the MUC1 antigen and prevents MUC1-mediated signaling. MUC1, a mucin antigen, is overexpressed in pancreatic cancer but not in normal, healthy pancreatic cells. |
|---|---|
| prefLabel | Clivatuzumab
|
| label | Clivatuzumab
|
| code | C88638
|
| prefixIRI | NCIT:C88638
|
| in_subset | |
| Preferred_Name | Clivatuzumab
|
| FDA_UNII_Code | RGU8A332UL
|
| Contributing_Source | FDA
|
| Maps_To | Clivatuzumab
|
| CAS_Registry | 1622075-09-5
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| Semantic_Type |
Pharmacologic Substance
Immunologic Factor
|
| UMLS_CUI | C2982120
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |